Doubly Robust Estimation with Stabilized Weights for Binary Proximal Outcomes in Micro-Randomized Trials
summary
The gist
Micro-randomized trials (MRTs) are increasingly used to evaluate mobile health interventions with binary proximal outcomes because standard inverse probability weighting (IPW) estimators are unbiased…
In short
This work introduces a Doubly Robust Excursion Effect Mean Estimator (DR-EMEE) for micro-randomized trials evaluating mobile health interventions with binary outcomes. It addresses the instability of standard inverse probability weighting by using weight stabilization and truncation, resulting in a method that is consistent, efficient, and robust even in small samples.
Key concepts
- Micro-Randomized Trials (MRTs)
- MRTs are an experimental design for mobile health studies where participants are randomized to treatment or control at each decision point. This allows researchers to observe short-term outcomes and estimate the causal effect of treatment delivery based on context and availability, which is crucial for adaptive interventions.
- Doubly Robust (DR) Estimation
- This statistical method combines inverse probability weighting (IPW) with outcome regression. It achieves consistency if either the treatment model or the outcome model is correctly specified, offering a robust way to estimate causal effects when one of the two models might be wrong.
- Excursion Effect
- The excursion effect is a key measure in MRTs that estimates how much the treatment delivery changes an outcome over a short window. Reliable estimation of this effect is vital for designing adaptive interventions and informing digital health policies.
- Weight Stabilization and Truncation
- These techniques are used to stabilize the highly variable weights produced by inverse probability weighting, especially in small samples. Truncation further reduces variance by limiting the influence of extreme weights, leading to more stable and reliable estimates.
Terminology used across episodes
This episode discusses
- Doubly Robust Estimation with Stabilized Weights for Binary Proximal Outcomes in Micro-Randomized Trials · Paper Radio
The paper
Doubly Robust Estimation with Stabilized Weights for Binary Proximal Outcomes in Micro-Randomized Trials · Read on arXiv
Jinho Cha, Eunchan Cha
Department of Computer Programming, Gwinnett Technical College · Department of Biology, Georgia Institute of Technology
Micro-randomized trials (MRTs) are increasingly used to evaluate mobile health interventions with binary proximal outcomes. Standard inverse probability weighting (IPW) estimators are unbiased but unstable in small samples or under extreme randomization. Estimated mean excursion effect (EMEE) improves efficiency but lacks double robustness. We propose a doubly robust EMEE (DR-EMEE) with stabilized and truncated weights, combining per-decision IPW and outcome regression. We prove double robustness, asymptotic efficiency, and provide finite-sample variance corrections, with extensions to machine learning nuisance estimators. In simulations, DR-EMEE reduces root mean squared error, improves coverage, and achieves up to twofold efficiency gains over IPW and five to ten percent over EMEE. Applications to HeartSteps, PAMAP2, and mHealth datasets confirm stable and efficient inference across both randomized and observational settings.
Transcript
Introduction to the show: ident: Statistics. The day in statistics: methods, theory and the inference under them.
Tom: We're looking at the paper: "Doubly Robust Estimation with Stabilized Weights for Binary Proximal Outcomes in Micro-Randomized Trials".
Jane: Here's the gist of the paper. Micro-randomized trials (MRTs) are increasingly used to evaluate mobile health interventions with binary proximal outcomes because standard inverse probability weighting (IPW) estimators are unbiased but unstable in small samples or under extreme randomization.
Tom: Micro-randomized trials (MRTs) have emerged as a central experimental design for evaluating just-in-time adaptive interventions (JITAIs) in mobile health (mHealth) studies.
Jane: At each decision time, participants are randomized to treatment or control, and proximal outcomes are observed over short windows.
Tom: This sequential structure enables the estimation of excursion effects, the causal effect of treatment delivery conditional on availability and context.
Paper summary: Tom: So we're talking about this paper today called "Doubly Robust Estimation with Stabilized Weights for Binary Proximal Outcomes in Micro-Randomized Trials". The core idea here is that micro-randomized trials are super useful for studying mobile health interventions because you can randomize participants at every decision time and see outcomes over short windows.
Jane: That's right, and the paper points out that standard methods, like inverse probability weighting or IPW, are unbiased but they get really unstable when you have small sample sizes or when the randomization is extreme.
Lu: The paper addresses this by proposing a new approach called DR-EMEE which combines inverse probability weighting with outcome regression, and they're adding some weight stabilization and truncation to keep things consistent.
Meng: So it's trying to fix the instability of the per-decision IPW estimator, which they call pd-IPW, that they say is unbiased but highly variable. What does this mean for us when we try to run these models at scale?
Lalam: It means they are trying to make sure that no matter if you're wrong about the treatment model or the outcome model, your final estimate of the mean excursion effect is still valid.
Tom: Exactly, and they claim this DR-EMEE estimator proves double robustness, which means it stays consistent if either your treatment model or your outcome model is specified correctly. That sounds pretty solid.
Jane: But they also focus on showing that this new method has asymptotic efficiency, meaning as the sample size gets bigger, it gets as good as the best possible estimator can get. How does that compare to what we usually have?
Lu: The paper shows that this approach achieves higher relative efficiency in simulation studies compared to standard methods like IPW and EMEE in balanced conditions. They even show a finite-sample variance correction is needed for small sample sizes, which they define as n over n minus p sigma squared.
Meng: That's interesting about the variance correction because I've seen how much standard sandwich variance estimators can underestimate variability when you only have a few clusters, and this seems to address that practical problem. What about when the treatment assignment probabilities are really extreme?
Lalam: They show that weight stabilization and truncation across different randomization probabilities progressively reduce variance and eliminate those heavy tails in the estimates. This is important because in mHealth trials, you often have very rare treatments, like a probability of zero point one or zero point nine.
Tom: It’s about making sure those extreme weights don't blow up the estimate, which they say standard IPW does. The simulation results show DR-EMEE consistently achieves higher relative efficiency and lower RMSE across all tested scenarios, including those with extreme randomization probabilities.
Jane: So what does this actually mean for someone who just listens to the show? It means that when you're looking at data from things like heart rate monitors or activity trackers, this method gives you a more reliable estimate of how much a specific intervention actually causes an effect.
Lu: For the person listening, it means they can trust the numbers they get from these complex mobile health trials even when the study design is tricky and the sample size is modest. They aren't just getting an estimate; they're getting one that has been proven to be robust under different kinds of model misspecification.
Meng: From a deployment standpoint, if we were trying to use this in a production setting, we’d want to know what breaks at scale and how much computational overhead this stabilization adds compared to just running the raw pd-IPW.
Lalam: The paper shows that even with these added steps of stabilization and truncation, DR-EMEE produces stable estimates with substantially narrower intervals than both IPW and EMEE on datasets like HeartSteps I and PAMAP2.
Tom: So to wrap up this part of the paper, it's about giving us a principled framework, the DR-EMEE estimator, for estimating causal effects in mobile health that is valid even in small samples or under extreme treatment probabilities. It’s a new way to handle those messy real-world trial designs.
Jane: The authors Jinho Cha and Eunchan Cha are focused on proving this consistency and showing its efficiency gains over existing doubly robust methods, especially where they've had less work done before in the micro-randomized trial setting. It's a big step for applying these powerful causal inference tools to digital health.
Lu: The implication here is that we can start designing adaptive interventions more reliably because we have a method that handles the inherent uncertainty of sequential decision-making better than what we had previously.
Meng: It moves us from just having an estimate to having a statistically sound foundation for making decisions about how those mobile health tools are actually working in practice.
Lalam: The paper establishes DR-EMEE as a reliable and scalable framework for advancing causal inference in digital health, which is what I’m pretty sure this work is really about.
Conclusion: Tom: So we're wrapping up our look at "Doubly Robust Estimation with Stabilized Weights for Binary Proximal Outcomes in Micro-Randomized Trials."
Jane: Basically, this paper is about a new way to estimate effects in mobile health studies that have been randomized frequently, which they call micro-randomized trials.
Lu: The authors are focusing on the doubly robust estimation method, specifically how it handles those binary outcomes you see over short time windows.
Meng: It tackles the problem of instability that standard inverse probability weighting estimators run into when your sample size is small or your treatment probabilities are very extreme.
Lalam: They introduce this DR-EMEE estimator, which they claim gives you consistent results even if you're slightly off on either the treatment model or the outcome model.
Tom: So, what does that mean in practice for someone trying to use these mobile health interventions? It means a more reliable estimate of whether an intervention actually works.
Jane: It means for people relying on heart rate monitors or activity trackers, they can trust the numbers better than before, especially when the study design is complex.
Lu: The paper shows that this method has better efficiency in simulations compared to older techniques like EMEE and IPW when things are balanced.
Meng: I'm interested in how this affects deployment; if we're shipping models into production, we need to know what the computational cost is for using these stabilized weights.
Tom: That’s a fair point, Meng, because the stabilization adds some complexity to the math and requires more careful tuning.
Jane: But it seems like that extra effort pays off in terms of getting a more accurate picture of reality, which is what matters for policy and clinical decisions.
Lu: It moves us closer to having a principled framework for digital health research where we can be more confident in our causal claims even with limited data.
Lalam: They also point out that they've got a trick for small sample sizes, like using n over n minus p sigma squared to fix the variance estimates when the number of clusters is low.
Tom: So, it’s not just about getting a better estimate; it’s about making sure that estimate doesn't have wildly unstable confidence intervals when you're dealing with small numbers.
Jane: Exactly, and that makes a huge difference for real-world data where you don't always get huge samples.
Lu: It also opens the door to thinking about how this framework might integrate with adaptive treatment allocation strategies down the road.
Meng: I'll have to see if those integration points are actually practical to implement without making the system too heavy for a production environment.
More episodes
- Daily Summary for 2026-11-19
- 2310.07973-Statistical Performance Guarantee for Subgroup Identification with Generic Machine Learning
- 2408.09155-Learning Robust Treatment Rules for Censored Data
- Daily Summary for 2026-11-19
- 2603.23397-Kinetic Langevin Splitting Schemes for Constrained Sampling
- 2606.09906-An information-geometric framework for mapping maximum potential biodiversity
- 2603.27718-Induced replication and the assessment of models
- 1307.0898-Entropy of a Zipfian Distributed Lexicon
- 2406.19974-Generalizing self-normalized importance sampling with couplings
- 2412.10213-Collaborative Optimal Design of Controlled Experiments with Subject Covariates